Simultaneous percutaneous treatment in hypertrophic obstructive cardiomyopathy and coronary artery disease: A case report

✍ Scribed by Seggewiss, Hubert ;Faber, Lothar ;Meyners, Werner ;Bogunovic, Nikola ;Odenthal, Hans-Jakob ;Gleichmann, Ulrich

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 131 KB
• Volume: 44
• Category: Article
• ISSN: 0098-6569
• DOI: 10.1002/(sici)1097-0304(199805)44:1<65::aid-ccd16>3.0.co;2-o

✦ Synopsis

Percutaneous transluminal coronary angioplasty (PTCA) is an established therapy for coronary artery disease (CAD), whereas percutaneous transluminal septal myocardial ablation (PTSMA) is becoming increasingly significant in the therapy of symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). We report the first ever simultaneous treatment, in a 62-yr-old patient, of significant HOCM and a 75% LAD stenosis from which the septal branch to be occluded stemmed. Using a double wire technique, first the septal branch was occluded through a fractional injection of 4 ml absolute alcohol, thus ablating the hypertrophied septal myocardium with reduction of the left ventricular outflow tract (LVOT) gradient at rest from 80 to 9 mmHg. Following this, the LAD stenosis was dilated and stented. Complications, in particular a trifascicular block or ventricular dysrhythmia, did not occur during the hospital stay. To conclude, combined PTSMA and PTCA may be considered as a therapeutic alternative to a combined surgical intervention in individual cases of symptomatic HOCM and CAD, provided that the potential complications are taken into account.